269 related articles for article (PubMed ID: 32125790)
21. SHCBP1 Is a Prognostic Biomarker Related to the Tumour Immune Microenvironment in Pan-Cancer.
Huang Y; You M; Wu Q; Zhu W; Guo F; Lin W
Ann Clin Lab Sci; 2022 Nov; 52(6):904-917. PubMed ID: 36564070
[TBL] [Abstract][Full Text] [Related]
22. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
Pototschnig I; Feiler U; Diwoky C; Vesely PW; Rauchenwald T; Paar M; Bakiri L; Pajed L; Hofer P; Kashofer K; Sukhbaatar N; Schoiswohl G; Weichhart T; Hoefler G; Bock C; Pichler M; Wagner EF; Zechner R; Schweiger M
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):93-107. PubMed ID: 36351437
[TBL] [Abstract][Full Text] [Related]
24. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients.
Fortunati N; Manti R; Birocco N; Pugliese M; Brignardello E; Ciuffreda L; Catalano MG; Aragno M; Boccuzzi G
Oncol Rep; 2007 Dec; 18(6):1521-7. PubMed ID: 17982639
[TBL] [Abstract][Full Text] [Related]
25. Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression.
Wu Q; Sun S; Li Z; Yang Q; Li B; Zhu S; Wang L; Wu J; Yuan J; Yang C; Li J; Sun S
Mol Cancer; 2018 Oct; 17(1):155. PubMed ID: 30359265
[TBL] [Abstract][Full Text] [Related]
26. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis.
Fearon KC; Voss AC; Hustead DS;
Am J Clin Nutr; 2006 Jun; 83(6):1345-50. PubMed ID: 16762946
[TBL] [Abstract][Full Text] [Related]
27. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Int J Biochem Cell Biol; 2005 May; 37(5):1084-104. PubMed ID: 15743680
[TBL] [Abstract][Full Text] [Related]
29. Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.
Nissinen TA; Hentilä J; Penna F; Lampinen A; Lautaoja JH; Fachada V; Holopainen T; Ritvos O; Kivelä R; Hulmi JJ
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):514-529. PubMed ID: 29722201
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic cancer cachexia: three dimensions of a complex syndrome.
Kordes M; Larsson L; Engstrand L; Löhr JM
Br J Cancer; 2021 May; 124(10):1623-1636. PubMed ID: 33742145
[TBL] [Abstract][Full Text] [Related]
31. Cancer cachexia.
Tisdale MJ
Curr Opin Gastroenterol; 2010 Mar; 26(2):146-51. PubMed ID: 19918173
[TBL] [Abstract][Full Text] [Related]
32. Understanding cachexia in the context of metastatic progression.
Biswas AK; Acharyya S
Nat Rev Cancer; 2020 May; 20(5):274-284. PubMed ID: 32235902
[TBL] [Abstract][Full Text] [Related]
33. Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals.
Toneto AT; Ferreira Ramos LA; Salomão EM; Tomasin R; Aereas MA; Gomes-Marcondes MC
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):577-586. PubMed ID: 27030817
[TBL] [Abstract][Full Text] [Related]
34. Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Adv Gerontol; 2006; 18():39-54. PubMed ID: 16676797
[TBL] [Abstract][Full Text] [Related]
35. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R
Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031
[TBL] [Abstract][Full Text] [Related]
36. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome.
Plata-Salamán CR
Nutrition; 2000 Oct; 16(10):1009-12. PubMed ID: 11054608
[TBL] [Abstract][Full Text] [Related]
37. C-reactive protein levels and vitamin d receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients.
Punzi T; Fabris A; Morucci G; Biagioni P; Gulisano M; Ruggiero M; Pacini S
Mol Diagn Ther; 2012 Apr; 16(2):115-24. PubMed ID: 22497530
[TBL] [Abstract][Full Text] [Related]
38. Cancer cachexia.
Tisdale MJ
Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
[TBL] [Abstract][Full Text] [Related]
39. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients.
Batista ML; Olivan M; Alcantara PS; Sandoval R; Peres SB; Neves RX; Silverio R; Maximiano LF; Otoch JP; Seelaender M
Cytokine; 2013 Feb; 61(2):532-9. PubMed ID: 23200412
[TBL] [Abstract][Full Text] [Related]
40. Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients.
Talbert EE; Lewis HL; Farren MR; Ramsey ML; Chakedis JM; Rajasekera P; Haverick E; Sarna A; Bloomston M; Pawlik TM; Zimmers TA; Lesinski GB; Hart PA; Dillhoff ME; Schmidt CR; Guttridge DC
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):358-368. PubMed ID: 29316343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
